25CN-NBOH jest penetrującym mózg, bardzo silnym i selektywnym agonistą receptora 5-HT2A (ludzki 2A/szczur 2C Ki = 1,3/132 nM; ludzki 2A/2C PI turnover EC50 = 2.1/190 nM) ze znacznie zmniejszoną skutecznością w stosunku do ludzkich podtypów 2B i 2C (stosunek Ki: 2C/2A = 52-81 i 2B/2A = 37; mobilizacja Ca2 + Δlog (stosunek Rmax/EC50: 2C/2A = 30-180 i 2B/2A = 54; stosunek 2C/2A PI turnover EC50 = 81-146) i innych receptorów / transporterów / kinaz. Po podaniu myszom in vivo (1, 3, 6 mg/kg s.c.), 25CN-NBOH wywołuje efekty podobne do halucynogenów, blokowane przez antagonistę 5-HT2A M100907, ale nie antagonistę 5-HT2C RS102221.
Wnikający do mózgu, silny i selektywny agonista receptora 5-HT2A o dobrej skuteczności in vitro i in vivo.
Przestroga
Higroskopijność
Ta strona może zawierać tekst przetłumaczony maszynowo.
2-([2-(4-cyano-2,5-dimethoxyphenyl)ethylamino]methyl)phenol (25CN-NBOH) is structurally similar to N-benzyl substituted phenethylamine hallucinogens currently emerging as drugs of abuse. 25CN-NBOH exhibits dramatic selectivity for 5-HT2A receptors in vitro, but has not been behaviorally characterized. 25CN-NBOH was compared to the traditional phenethylamine hallucinogen R(-)-2,5-dimethoxy-4-iodoamphetamine
The serotonin (5-HT) 2A receptor is the primary molecular target of serotonergic hallucinogens, which trigger large-scale perturbations of the cortex. Our understanding of how 5-HT2A activation may cause the effects of hallucinogens has been hampered by the receptor unselectivity of
5-Hydroxytryptamine 2A receptor (5-HT2AR) agonist psychedelics are increasingly recognized as potentially useful treatments of psychiatric disorders, such as obsessive-compulsive disorder, depression, anxiety, and drug dependence. There is limited understanding of the way they exert their therapeutic action, but inhibition of
Journal of psychopharmacology (Oxford, England), 34(7), 786-794 (2020-02-13)
Serotonin 2A receptors, the molecular target of psychedelics, are expressed by neuronal and vascular cells, both of which might contribute to brain haemodynamic characteristics for the psychedelic state. Aiming for a systemic understanding of psychedelic vasoactivity, here we investigated the
ACS chemical neuroscience, 5(3), 243-249 (2014-01-09)
N-Benzyl substitution of 5-HT2A receptor agonists of the phenethylamine structural class of psychedelics (such as 4-bromo-2,5-dimethoxyphenethylamine, often referred to as 2C-B) confer a significant increase in binding affinity as well as functional activity of the receptor. We have prepared a
Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.